Your browser doesn't support javascript.
loading
Intravaginal delivery for CRISPR-Cas9 technology: For example, the treatment of HPV infection.
Zhen, Shuai; Chen, Hong; Lu, Jiaojiao; Yang, Xiling; Tuo, Xiaoqian; Chang, Shixue; Tian, Yuhan; Li, Xu.
Afiliação
  • Zhen S; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Chen H; Genetic Disease Diagnosis Center of Shaanxi Province, Xi'an, Shaanxi, China.
  • Lu J; Medical Genetics Centre, Northwest Women's and Children's Hospital, Xi'an, China.
  • Yang X; Department of Pharmacy, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Tuo X; Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Chang S; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Tian Y; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Li X; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
J Med Virol ; 95(2): e28552, 2023 02.
Article em En | MEDLINE | ID: mdl-36734062
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Nanopartículas Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Nanopartículas Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article